New betulinic acid derivatives as potent proteasome inhibitors.

Journal Article (Journal Article)

In this study, 22 new betulinic acid (BA) derivatives were synthesized and tested for their inhibition of the chymotrypsin-like activity of 20S proteasome. From the SAR study, we concluded that the C-3 and C-30 positions are the pharmacophores for increasing the proteasome inhibition effects, and larger lipophilic or aromatic side chains are favored at these positions. Among the BA derivatives tested, compounds 13, 20, and 21 showed the best proteasome inhibition activity with IC(50) values of 1.42, 1.56, and 1.80 μM, respectively, which are three to fourfold more potent than the proteasome inhibition controls LLM-F and lactacystin.

Full Text

Duke Authors

Cited Authors

  • Qian, K; Kim, S-Y; Hung, H-Y; Huang, L; Chen, C-H; Lee, K-H

Published Date

  • October 1, 2011

Published In

Volume / Issue

  • 21 / 19

Start / End Page

  • 5944 - 5947

PubMed ID

  • 21856154

Pubmed Central ID

  • PMC3171619

Electronic International Standard Serial Number (EISSN)

  • 1464-3405

Digital Object Identifier (DOI)

  • 10.1016/j.bmcl.2011.07.072


  • eng

Conference Location

  • England